-
By John K. Waters
Researchers at Microsoft's AI for Good Lab and the University of Washington have developed an artificial intelligence model that could reduce false positives in breast cancer screening while providing clearer explanations for its decisions.
Read More
-
By John K. Waters
Alphabet's Isomorphic Labs says it's nearly ready to begin clinical trials on drugs designed entirely with artificial intelligence, a move that could reshape how new medicines are developed, but still faces a long and uncertain road ahead.
Read More
-
By John K. Waters
Swiss health technology company Aktiia has received FDA 510(k) clearance for its G0 Blood Pressure Monitoring System, becoming the first cuffless blood pressure monitor approved for over-the-counter use in the United States.
Read More
-
By John K. Waters
A new diagnostic system developed by Microsoft AI researchers has outperformed practicing physicians in a series of complex clinical cases, offering a glimpse into how generative artificial intelligence could transform high-stakes medical decision making.
Read More
-
By John K. Waters
Johnson & Johnson MedTech, the company's medical technology division has established a new artificial intelligence fund aimed at advancing surgical applications, partnering with Nvidia and Amazon Web Services to evaluate proposals and provide technical resources.
Read More
-
By John K. Waters
Software platform provider Vantiq has formed a partnership with consulting firm Huron to implement artificial intelligence systems in hospital operations, starting with command centers that manage critical healthcare functions.
Read More
-
By John K. Waters
Stand Up to Cancer (SU2C) has announced a partnership with technology firm SandboxAQ aimed at accelerating the development of cancer treatments through advanced artificial intelligence tools.
Read More
-
By John K. Waters
SIME Diagnostics, a UK-based medical technology firm, has completed a clinical study evaluating an artificial intelligence-powered Lung Maturity Test (LMT) designed to identify respiratory risks in late-preterm newborns in the United States.
Read More
-
By John K. Waters
OpenAI launches HealthBench, a massive new benchmark that's the company's first major independent health care project.
Read More
-
By John K. Waters
Life sciences software company ACTO has announced an upcoming release of its next-generation Life Sciences AI Conversational Assistant (LAICA), aimed at improving information access and interaction quality for pharmaceutical field teams.
Read More
-
By John K. Waters
Global medical technology firm BD (Becton, Dickinson and Company) has launched a new cell analysis instrument that combines two advanced technologies—spectral flow cytometry and real-time cell imaging—into a single platform, aiming to expand the range of cell-based experiments in biomedical research.
Read More
-
By John K. Waters
Minnesota-based medtech firm iotaMotion has announced the first use of its iotaSOFT Insertion System outside the United States as part of a pre-market clinical investigation at the University Hospital of Zurich in Switzerland.
Read More
-
By John K. Waters
AI and quantum computing company SandboxAQ has announced a new collaboration with NVIDIA aimed at accelerating breakthroughs in drug development, therapeutic design, and medical imaging through the deployment of a new AI platform built on NVIDIA's DGX Cloud infrastructure.
Read More
-
By John K. Waters
Voice AI company Deepgram has unveiled Nova 3 Medical, a next-generation speech-to-text model built specifically for the healthcare sector, claiming it delivers the most accurate real-time medical transcription on the market.
Read More
-
By John K. Waters
PDS Health announces the launch of PDS Health Technologies, a new division aimed at extending its data-driven care infrastructure and expanding access to integrated electronic health record (EHR) solutions across a broader network of providers.
Read More
-
By John K. Waters
The global market for nanotechnology in medical devices is set for significant growth, driven by technological advancements, increasing healthcare demands, and a shift towards precision medicine. According to a newly released report by Research And Markets, the sector was valued at $3.4 billion in 2024 and is projected to reach $4.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.4%.
Read More